ArticleJournal of advanced pharmaceutical technology & research
Development of a synbiotic water kefir, dragon fruit, and inulin-medium-chain triglyceride drink as a candidate for an antihyperlipidemic beverage.
Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Consumer demand for palatable functional beverages with metabolic health benefits is increasing. Water kefir is a plant-based probiotic drink associated with improved metabolic profiles, immune modulation, and anti-inflammatory effects. Combining probiotics with prebiotics (synbiotics) may further enhance these benefits, although synbiotic beverages remain underdeveloped. This study aimed to develop and characterize a synbiotic water kefir beverage formulated with red dragon fruit and 20% inulin-medium-chain triglycerides (MCTs) as a potential Indonesian functional beverage. Physicochemical stability (pH and viscosity) was evaluated during 95 days of production. Microbiological safety (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.